These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14581798)

  • 1. Increased levels of hemostatic proteins are independent of inflammation in glycogen storage disease type Ia.
    Marfaing-Koka A; Wolf M; Boyer-Neumann C; Meyer D; Odievre M; Labrune P
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):566-70. PubMed ID: 14581798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.
    Kim SY; Weinstein DA; Starost MF; Mansfield BC; Chou JY
    J Hepatol; 2008 Mar; 48(3):479-85. PubMed ID: 18191274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia.
    Mühlhausen C; Schneppenheim R; Budde U; Merkel M; Muschol N; Ullrich K; Santer R
    J Inherit Metab Dis; 2005; 28(6):945-50. PubMed ID: 16435187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.
    Lee PJ; Patel A; Hindmarsh PC; Mowat AP; Leonard JV
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profiling in patients with hepatic glycogen storage disease: Are there clues for unsolved aspects?
    Colonetti K; Pinto E Vairo F; Siebert M; Nalin T; Poloni S; Fernando Wurdig Roesch L; Fischinger Moura de Souza C; Cabral Pinheiro F; Vanessa Doederlein Schwartz I
    Cytokine; 2023 Feb; 162():156088. PubMed ID: 36462220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III.
    Yekeler E; Dursun M; Emeksiz E; Akkoyunlu M; Akyol Y; Demir F; Gökcay G; Demirkol M
    Turk J Pediatr; 2007; 49(2):115-9. PubMed ID: 17907509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.
    Peeks F; Steunenberg TAH; de Boer F; Rubio-Gozalbo ME; Williams M; Burghard R; Rajas F; Oosterveer MH; Weinstein DA; Derks TGJ
    J Inherit Metab Dis; 2017 Sep; 40(5):695-702. PubMed ID: 28397058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained high plasma mannose less sensitive to fluctuating blood glucose in glycogen storage disease type Ia children.
    Nagasaka H; Yorifuji T; Bandsma RH; Takatani T; Asano H; Mochizuki H; Takuwa M; Tsukahara H; Inui A; Tsunoda T; Komatsu H; Hiejima E; Fujisawa T; Hirano K; Miida T; Ohtake A; Taguchi T; Miwa I
    J Inherit Metab Dis; 2013 Jan; 36(1):75-81. PubMed ID: 22971957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.
    Nagasaka H; Hirano K; Ohtake A; Miida T; Takatani T; Murayama K; Yorifuji T; Kobayashi K; Kanazawa M; Ogawa A; Takayanagi M
    Eur J Pediatr; 2007 Oct; 166(10):1009-16. PubMed ID: 17206455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.
    Kishnani PS; Chuang TP; Bali D; Koeberl D; Austin S; Weinstein DA; Murphy E; Chen YT; Boyette K; Liu CH; Chen YT; Li LH
    Hum Mol Genet; 2009 Dec; 18(24):4781-90. PubMed ID: 19762333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia.
    La Rose AM; Bazioti V; Hoogerland JA; Svendsen AF; Groenen AG; van Faassen M; Rutten MGS; Kloosterhuis NJ; Dethmers-Ausema B; Nijland JH; Mithieux G; Rajas F; Kuipers F; Lukens MV; Soehnlein O; Oosterveer MH; Westerterp M
    Mol Metab; 2021 Nov; 53():101265. PubMed ID: 34091064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    J Trace Elem Med Biol; 2010 Jan; 24(1):42-5. PubMed ID: 20122579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic ultrasound findings in the glycogen storage diseases.
    Lee P; Mather S; Owens C; Leonard J; Dicks-Mireaux C
    Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for glycogen storage disease type Ia.
    Reddy SK; Austin SL; Spencer-Manzon M; Koeberl DD; Clary BM; Desai DM; Smith AD; Kishnani PS
    J Hepatol; 2009 Sep; 51(3):483-90. PubMed ID: 19596478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of changes in levels of haemostatic variables during natural menstrual cycle and ovarian hyperstimulation.
    Andersson O; Blombäck M; Bremme K; Wramsby H
    Thromb Haemost; 1997 May; 77(5):901-4. PubMed ID: 9184400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker.
    Paesold-Burda P; Baumgartner MR; Santer R; Bosshard NU; Steinmann B
    J Inherit Metab Dis; 2007 Nov; 30(6):896-902. PubMed ID: 17994282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin levels correlate with the severity of hypertriglyceridaemia in glycogen storage disease Ia.
    Bandsma RH; Smit GP; Reijngoud DJ; Kuipers F
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S27-31. PubMed ID: 19267215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients.
    Nguyen AD; Pan CJ; Weinstein DA; Chou JY
    Mol Genet Metab; 2006 Nov; 89(3):233-8. PubMed ID: 16777453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia.
    Rutten MGS; Lei Y; Hoogerland JH; Bloks VW; Yang H; Bos T; Krishnamurthy KA; Bleeker A; Koster MH; Thomas RE; Wolters JC; van den Bos H; Mithieux G; Rajas F; Mardinoglu A; Spierings DCJ; de Bruin A; van de Sluis B; Oosterveer MH
    Cancer Metab; 2023 Apr; 11(1):5. PubMed ID: 37085901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.